Dr. Jose Rubio, a psychiatrist at Long Island Jewish Medical Center and Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, was kind enough to join me for this 10-minute interview on the merits of long-acting antipsychotics for the treatment of schizophrenia. You can listen to our discussion on ReachMD.com here: https://reachmd.com/programs/neurofrontiers/reducing-relapse-for-schizophrenia-patients-a-look-at-lai-antipsychotics/13326/

Treatment-resistant schizophrenia is a common and vexing therapeutic challenge. During a fascinating interview on ReachMD with Dr. Nicola Cascella, an Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine, I learned of a pioneering new approach. Dr. Cascella had success with one patient by applying neuromodulation therapy--specifically deep brain stimulation of the substantial nigra pars reticulata. Listen here for the detai